S. Harrison

发表

Modulation of cytosine arabinoside toxicity by 3-deazauridine in a murine leukemia model.

L. Rubinstein, J. Grem, J. Plowman, 1991, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł.

A. Malkinson, A. Gazdar, P. Bunn, 1992, Cancer research.

Response of human tumor xenografts in athymic nude mice to docetaxel (RP 56976, Taxotere®)

M. Bissery, W. Waud, D. Dykes, 2007, Investigational New Drugs.

Partial Inhibition of Multidrug Resistance by Safingol Is Independent of Modulation of P-glycoprotein Substrate Activities and Correlated with Inhibition of Protein Kinase C (*)

R. Fine, A. Safa, C. Sachs, 1995, The Journal of Biological Chemistry.

Tumor models in drug development

D. Griswold, S. Harrison, 1991, Cancer and Metastasis Reviews.

Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents.

R. L. Hall, H. Bozigian, T. Palmer, 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice

J. Plowman, W. Waud, D. Dykes, 2004, Cancer Chemotherapy and Pharmacology.

Preclinical antitumor activity of penclomedine in mice: cross-resistance, schedule dependence, and oral activity against tumor xenografts in brain.

J. Plowman, W. Waud, D. Dykes, 1991, Cancer research.

Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumors.

K. Paull, J. Plowman, D. Dykes, 1989, Cancer research.

Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II)

D. Griswold, M. Trader, S. Harrison, 2004, Cancer Chemotherapy and Pharmacology.

Cross-resistance of drug-resistant murine leukemias to deoxyspergualin (NSC 356894) in vivo

R. W. Brockman, W. R. Laster, D. Griswold, 1987, Investigational New Drugs.

Development of Human Tumor Xenograft Models for In Vivo Evaluation of New Antitumor Drugs

B. Abbott, J. Mayo, D. Dykes, 1992 .

Effect of aspirin administration on retinoic acid toxicity in mice

E. P. Denine, S. Harrison, J. Burdeshaw, 1977, Nature.

Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.

P. O'dwyer, J. Plowman, T. Hamilton, 1994, Cancer research.

Correlation of metal toxicity with in vitro calmodulin inhibition.

S. Harrison, J. L. Cox, 1983, Biochemical and biophysical research communications.

Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo

J. Plowman, W. Waud, D. Dykes, 2004, Cancer Chemotherapy and Pharmacology.

Physiological disposition of atropine in the rat.

R. P. Maickel, S. Harrison, T. Bosin, 1974, Pharmacology, biochemistry, and behavior.

Comparative physiological disposition of melatonin and its benzo(b)thiophene analog in the rat.

M. Riddle, R. P. Maickel, S. Harrison, 1974, Life sciences.

Preclinical antitumor activity and pharmacological properties of deoxyspergualin.

J. Plowman, D. Griswold, D. Zaharko, 1987, Cancer research.

Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.

P. O'dwyer, M. Trader, S. Harrison, 1986, Cancer research.

Qualitative and quantitative toxicity of single and sequential sublethal doses of 5-fluorouracil in BDF mice.

E. P. Denine, J. Peckham, S. Harrison, 1978, Cancer treatment reports.

Hematology and clinical chemistry reference values for C57BL/6 X DBA/2 F1 mice.

E. P. Denine, S. Harrison, J. Burdeshaw, 1978, Cancer research.

Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia

W. Waud, W. R. Laster, D. Griswold, 2004, Cancer Chemotherapy and Pharmacology.

Arabinosyl-5-azacytosine: A novel nucleoside entering clinical trials

B. Leyland-Jones, J. Grem, J. Plowman, 1987, Investigational New Drugs.

An investigation of the mouse as a model for vincristine toxicity

S. Harrison, 2004, Cancer Chemotherapy and Pharmacology.

Perspective on the History of Tumor Models

S. Harrison, 2002 .

Evaluation of the antitumor activity of recombinant human gamma-interferon employing human melanoma xenografts in athymic nude mice.

P. Trotta, S. Harrison, 1987, Cancer research.

Practical spontaneous metastasis model for in vivo therapeutic studies using a human melanoma.

M. Boyd, R. Shoemaker, O. Fodstad, 1991, Cancer research.

Antitumor activity of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenyl-pyrido [3,4-b]pyrazin-7-ylcarbamate, 2-hydroxyethanesulfonate, hydrate (NSC 370147) against selected tumor systems in culture and in mice.

W. Elliott, W. Waud, W. R. Laster, 1990, Cancer research.

Qualitative and quantitative toxicity of sublethal doses of methyl-CCNU in BDF1 mice.

E. P. Denine, J. Peckham, S. Harrison, 1977, Cancer treatment reports.

Toxicologic evaluation of cis-diamminedichloroplatinum II in B6D2F1 mice.

S. Harrison, 1981, Fundamental and applied toxicology : official journal of the Society of Toxicology.

Evaluation of combinations of interferons and cytotoxic drugs in murine tumor models in vivo.

W. Waud, S. Schmid, D. Dykes, 1990, Journal of Biological Response Modifiers.

Antitumor drug toxicity in tumor-free and tumor-bearing mice

E. P. Denine, S. Harrison, H. Giles, 2004, Cancer Chemotherapy and Pharmacology.

Effects of prochlorperazine on experimental nephrotoxicity

S. Harrison, R. Giles, J. L. Cox, 1982, Cancer Chemotherapy and Pharmacology.

Hematologic and histopathologic evaluation of N-(phosphonacetyl)-l-aspartate (PALA) in mice

E. P. Denine, S. Harrison, H. Giles, 2004, Cancer Chemotherapy and Pharmacology.

Mosaic analysis using FLP recombinase.

T. Xu, S. Harrison, 1994, Methods in cell biology.

Cross-resistance of drug-resistant murine P388 leukemias to toxol in vivo

W. Waud, D. Griswold, S. Harrison, 2004, Cancer Chemotherapy and Pharmacology.

Short communication Cross-resistance of drug-resistant murine P388 leukemias to taxol in vivo*

D. Griswold, S. Harrison, K. Gilbert, 1992 .

Inhibition of intracellular Ca2+ signalling, cytotoxicity and antitumor activity of the herbicide oryzalin and its analogues

G. Powis, R. Abraham, A. Gallegos, 1997, Cancer Chemotherapy and Pharmacology.

Chapter 13 – Clinical Biochemistry

S. Harrison, R. Everett, 1983 .

Tween 80 increases plasma adriamycin concentrations in mice by an apparent reduction of plasma volume.

S. M. McAfee, S. Harrison, A. M. Cusic, 1981, European journal of cancer.

Effect of nitrosoureas on calmodulin activity in vitro and in mouse intestine in vivo

S. Harrison, R. Giles, D. Mann, 2004, Cancer Chemotherapy and Pharmacology.

Preclinical antitumor activity of batracylin (NSC 320846)

K. Paull, J. Plowman, D. Dykes, 1988, Investigational New Drugs.

Comparative subchronic toxicity of all-trans- and 13-cis- retinoic acid in Sprague--Dawley rats.

E. P. Denine, S. Harrison, J. Burdeshaw, 1979, Toxicology and applied pharmacology.

Excision assay for initial evaluation of antitumor drug activity in mice bearing human tumor xenografts.

J. Mayo, D. Dykes, D. Griswold, 1992, Journal of the National Cancer Institute.

A very early induction of major vault protein accompanied by increased drug resistance in U‐937 cells

L. Rome, V. Devanarayan, A. Stephen, 2002, International journal of cancer.

Polyamide thin-layer chromatographic separation of DOPA metabolites and related compounds.

R. P. Maickel, S. Harrison, P. Chiu, 1973, Journal of chromatography.

Inhibitory effects of calmodulin antagonists on urinary enzyme excretion in rats after nephrotoxic doses of mercuric chloride

S. Harrison, R. Giles, J. L. Cox, 1985, Bulletin of environmental contamination and toxicology.